NCT05248932View on ClinicalTrials.gov

Norepinephrine to Prevent Hypotension in Ceasrean Delivery

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 20, 2021

Primary Completion Date

May 20, 2022

Study Completion Date

June 20, 2022

Conditions
HypotensionCesarean Section Complications
Interventions
DRUG

Norepinephrine bolus

5 microgram bolus therapy

DEVICE

cardiometry

cardiac output, stroke volume and fluid responsiveness monitoring

DRUG

Norepinephrine infusion

2.5 microgram/min infusion

Trial Locations (1)

32511

Faculty of Medicine, University Hospitals, Shibīn al Kawm

All Listed Sponsors
lead

Menoufia University

OTHER

NCT05248932 - Norepinephrine to Prevent Hypotension in Ceasrean Delivery | Biotech Hunter | Biotech Hunter